Back stories here
Bristol-Myers Squibb Co. agreed to pay $2.1 million to settle a U.S. Federal Trade Commission lawsuit filed today over statements it made about a failed 2006 agreement involving the blood-thinner Plavix.
The FTC, in a complaint in federal court in Washington, accused the New York-based drugmaker of concealing material information about the agreement and violating a 2003 consent order it reached with the agency in another case that limited its ability to sign settlements in patent suits.
More at Bloomberg
No comments:
Post a Comment